As previously reported, lovastatin and fenofibrate, which have been routinely used in the clinical treatment of hyperlipidemia patients, showed a protective effect on the TGF-β-induced activation of HBFs from asthmatics [22,23]. Here, TGFB1 is linked to hyperlipidemia.